AC Immune reports positive TDP-43 tracer data in ALS patients

May 22, 2026 7:00 AM

AC Immune SA (NASDAQ: ACIU) announced preliminary Phase 1 data showing its TDP-43 PET tracer ACI-19626 demonstrated increased uptake in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found